Trials / Completed
CompletedNCT01814189
Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment: a Randomized, Double Blind Clinical Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 350 (actual)
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to show the efficacy of promethazine in management of patients with moderate to severe migraine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sumatriptan+Promethazine (SPr) |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2013-03-19
- Last updated
- 2013-07-30
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01814189. Inclusion in this directory is not an endorsement.